Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05187910 · ClinicalTrials.gov registry record · NA

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
57
Enrollment target

NCT05187910 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 57 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05187910, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target

Study Summary

This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngology treatment seeking patients. The relationship between the scores of MoCA and parameters in therapy will be analyzed. The outcomes of this study could potentially impact how investigators determine candidacy for therapy and develop patient treatment plans to meet their needs. This is a collaborative study with Emory Voice Center and the NYU Voice Center.

Interventions

  • BEHAVIORAL Speech Therapy
  • BEHAVIORAL Swallowing Therapy
  • BEHAVIORAL Upper Airway Therapy

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2021-03-01
Est. Completion 2023-07-01
Phase NA

What the Registry Record Tells You About NCT05187910

The ClinicalTrials.gov registry entry for NCT05187910 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Speech Therapy is the first listed.

NCT05187910 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05187910 about?

NCT05187910 is a clinical study titled "Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population". This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngology treatment seeking patients. The relationship between the scores of MoCA and parameters in thera...

What is the current status of trial NCT05187910?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2021-03-01. Estimated completion is 2023-07-01.

What interventions are being tested in trial NCT05187910?

The interventions under investigation include: Speech Therapy (BEHAVIORAL), Swallowing Therapy (BEHAVIORAL), Upper Airway Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05187910?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.